Post on 02-Jan-2016
description
transcript
by Lilien CheminformaticsUniversity of Toronto, December 2009SynPlan@gmail.com
1
University of Toronto, December 2009
Chemists use pen & paper to generate reaction plans for target molecule.
...over 100 million chemical substances and sequences! 2
Automate Planning
Reduce scale-up time from 2 yrs to 2 months
Extended patent protection
Discover new reaction pathways.
University of Toronto, December 2009 3
University of Toronto, December 2009 4Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009
BUSINESS MODEL CANVASInfrastructureInfrastructure CustomerCustomer
FinanceFinance
University of Toronto, December 2009 4
InfrastructureInfrastructure
Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009
BUSINESS MODEL CANVAS
Key ActivitiesPartner Network
Key Resources
R&D
Experts in chemistry & technology.
Academia
Reaction DB
Education
& Training
Publishing Companies
CustomerCustomer
FinanceFinance
University of Toronto, December 2009 4
CustomerCustomerInfrastructureInfrastructure
Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009
BUSINESS MODEL CANVAS
Key ActivitiesPartner Network
Key Resources
R&D
Experts in chemistry & technology.
Academia
Reaction DB
Education
& Training
Publishing Companies
Pharmaceutical companies
Distribution Channel
Training, Support
Reaction DB updates
Website with
cd/dvds of products
Networking within
Universities
FinanceFinance
FinanceFinance
University of Toronto, December 2009 4
CustomerCustomerInfrastructureInfrastructure
Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009
BUSINESS MODEL CANVAS
Key ActivitiesPartner Network
Key Resources
R&D
Experts in chemistry & technology.
Academia
Reaction DB
Education
& Training
Publishing Companies
Pharmaceutical companies
Distribution Channel
Training, Support
Reaction DB updates
Website with
cd/dvds of products
Networking within
Universities
Cost Structure Revenue Streams
Yearly Licensing
ModelSupport
Maintenance
Staff
R&D
Marketing
University of Toronto, December 2009 5
Completeness
ARChem
Theresa
SynChem
LHASA
University of Toronto, December 2009 6
Expertise Over 10 years of research
Partners Close relations industry
contacts
Opportunity Increasing cost Decreased drug approval
University of Toronto, December 2009
Peter Park, CEO
Brian Keng, CFO
Dejana Bajic, VP Sales and Marketing
Maryah Safi, VP Product Development
Amanda Manarin, Sales and Finance7
University of Toronto, December 2009 8
Total Operating Costs Total Revenue
Net Earnings
University of Toronto, December 2009
Invest $1.2 million: Alpha release of product Covers cash flow for first year Establish contacts with phamas
9